1-6 of 6
Keywords: Non-muscle invasive bladder cancer
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Rare Case of a Plasmacytoid and Sarcomatoid Differentiated Urothelial Bladder Carcinoma with a Single Metastasis to the Right Ventricle of the Heart and Rapid Review of Single Heart Metastasis in Bladder Cancer

Available to Purchase
Subject Area:
Further Areas
Kai Alexander Münker, David Reineke, Laila Schneidewind, Charlotte Müssgens
Journal: Urologia Internationalis
Urol Int (2025)
https://doi.org/10.1159/000546149
Published Online: 26 April 2025
...Kai Alexander Münker; David Reineke; Laila Schneidewind; Charlotte Müssgens Introduction: Distant metastases and especially single side metastases of non-muscle invasive bladder cancer (NMIBC) without regional progression in lymph nodes are extremely uncommon and rare. Case Presentation: We report...
View article titled, A Rare Case of a Plasmacytoid and Sarcomatoid Differentiated Urothelial Bladder Carcinoma with a Single Metastasis to the Right Ventricle of the Heart and Rapid Review of Single Heart Metastasis in Bladder Cancer
Open the PDF for A Rare Case of a Plasmacytoid and Sarcomatoid Differentiated Urothelial Bladder Carcinoma with a Single Metastasis to the Right Ventricle of the Heart and Rapid Review of Single Heart Metastasis in Bladder Cancer in another window
Journal Articles

Quality of Life, Efficacy, and Safety of Sequential Intravesical Gemcitabine + Docetaxel versus BCG for Non-Muscle Invasive Urinary Bladder Cancer: A Pilot Study

Free
Subject Area:
High Impact Articles in Further Areas , Further Areas
Tarun Pareek, Kalpesh Parmar, Aditya Prakash Sharma, Santosh Kumar
Journal: Urologia Internationalis
Urol Int (2022) 106 (8): 784–790.
https://doi.org/10.1159/000524098
Published Online: 23 August 2022
...Tarun Pareek; Kalpesh Parmar; Aditya Prakash Sharma; Santosh Kumar Purpose: Bacille Calmette-Guerin (BCG) is considered the most effective agent for non-muscle invasive bladder cancer (NMIBC). However, due to BCG-related toxicity, multiple studies have suggested the role of newer chemotherapeutic...
View article titled, Quality of Life, Efficacy, and Safety of Sequential Intravesical Gemcitabine + Docetaxel versus BCG for Non-Muscle Invasive Urinary Bladder Cancer: A Pilot Study
Open the PDF for Quality of Life, Efficacy, and Safety of Sequential Intravesical Gemcitabine + Docetaxel versus BCG for Non-Muscle Invasive Urinary Bladder Cancer: A Pilot Study in another window
Journal Articles

Human Epidermal Growth Factor Receptor 2 in Non-Muscle Invasive Bladder Cancer: Issues in Assessment Methods and Its Role as Prognostic/Predictive Marker and Putative Therapeutic Target: A Comprehensive Review

Available to Purchase
Subject Area:
Further Areas
Francesca Sanguedolce, Davide Russo, Vito Mancini, Oscar Selvaggio, Beppe Calò, Giuseppe Carrieri, Luigi Cormio
Journal: Urologia Internationalis
Urol Int (2019) 102 (3): 249–261.
https://doi.org/10.1159/000494359
Published Online: 21 November 2018
... to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Bladder cancer Non-muscle invasive bladder cancer Human epidermal growth factor receptor 2 Prognosis Therapeutic target Bladder cancer (BC) is the ninth most...
View article titled, Human Epidermal Growth Factor Receptor 2 in Non-Muscle Invasive Bladder Cancer: Issues in Assessment Methods and Its Role as Prognostic/Predictive Marker and Putative Therapeutic Target: A Comprehensive Review
Open the PDF for Human Epidermal Growth Factor Receptor 2 in Non-Muscle Invasive Bladder Cancer: Issues in Assessment Methods and Its Role as Prognostic/Predictive Marker and Putative Therapeutic Target: A Comprehensive Review in another window
Journal Articles

Observational Studies Requested by European Health Authorities: Governmental Interference or an Enhancement of Everyday Urological Practice? The Hexvix® Observational Patients Evaluation Study as an Example of What to Expect

Available to Purchase
Subject Area:
Further Areas
Didier Jacqmin, Patrice Jichlinski, Laurent Molinier, Alexandre de la Taille, Jacques Irani, Bernard Malavaud
Journal: Urologia Internationalis
Urol Int (2017) 99 (3): 358–366.
https://doi.org/10.1159/000477973
Published Online: 19 October 2017
... and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. 2017 European Union regulation Observational studies Hexaminolevulinate Non-muscle invasive bladder cancer...
View article titled, Observational Studies Requested by European Health Authorities: Governmental Interference or an Enhancement of Everyday Urological Practice? The Hexvix® Observational Patients Evaluation Study as an Example of What to Expect
Open the PDF for Observational Studies Requested by European Health Authorities: Governmental Interference or an Enhancement of Everyday Urological Practice? The Hexvix® Observational Patients Evaluation Study as an Example of What to Expect in another window
Journal Articles

Survival after Radical Cystectomy for Bladder Cancer in Relation to Prior Non-Muscle Invasive Disease in Quebec

Available to Purchase
Subject Area:
Further Areas
Ahmed S. Zakaria, Fabiano Santos, Wassim Kassouf, Simon Tanguay, Armen Aprikian
Journal: Urologia Internationalis
Urol Int (2016) 97 (1): 49–53.
https://doi.org/10.1159/000444093
Published Online: 11 February 2016
...Ahmed S. Zakaria; Fabiano Santos; Wassim Kassouf; Simon Tanguay; Armen Aprikian Introduction and Objectives: The aim of this study was to assess if there is a difference in survival after radical cystectomy (RC) when examined in relation to prior non-muscle invasive bladder cancer (NMIBC) disease...
View article titled, Survival after Radical Cystectomy for Bladder Cancer in Relation to Prior Non-Muscle Invasive Disease in Quebec
Open the PDF for Survival after Radical Cystectomy for Bladder Cancer in Relation to Prior Non-Muscle Invasive Disease in Quebec in another window
Journal Articles

Does the Compliance to Intravesical BCG Differ between Common Clinical Practice and International Multicentric Trials?

Available to Purchase
Subject Area:
Further Areas
Vincenzo Serretta, Cristina Scalici Gesolfo, Vincenza Alonge, Giuseppe Cicero, Marco Moschini, Renzo Colombo
Journal: Urologia Internationalis
Urol Int (2016) 96 (1): 20–24.
https://doi.org/10.1159/000430501
Published Online: 28 January 2016
... high-risk non-muscle invasive bladder cancer (NMIBC). However, almost 50% of patients don't complete it. Toxicity accounts for 10% of dropouts in international trials. Materials and Methods: Patients with T1HG NMIBC undergoing 1-year BCG were enrolled in this study. BCG was administered for one year...
View article titled, Does the Compliance to Intravesical BCG Differ between Common Clinical Practice and International Multicentric Trials?
Open the PDF for Does the Compliance to Intravesical BCG Differ between Common Clinical Practice and International Multicentric Trials? in another window